Literature DB >> 25113254

A functional and protein-protein interaction analysis of neuroepithelial cell transforming gene 1 in hepatocellular carcinoma.

Ke Ye1, Shi Chang, Jindong Li, Xinying Li, Yuedu Zhou, Zhiming Wang.   

Abstract

In our previous study, we reported that the expression of neuroepithelial transforming gene 1 (NET1) was increased in hepatocellular carcinoma (HCC) tissues and suggested that NET1 may serve as a novel prognostic predictor and a useful target for HCC therapy. The aim of this study was to determine the role of NET1 in HCC by monitoring the proliferation, migration, invasion, and metastasis of HCC cells in which NET1 has been stably knocked down. Additionally, to provide targets for therapeutic intervention, we aimed to identify the protein which interacts with NET1. NET1 knockdown significantly reduced the migration, invasion, and metastasis of MHCC-97H cells by 44, 65, and 77%, respectively, while cell proliferation was not significantly altered following NET1 knockdown. During our efforts to find potential NET1 modulators through protein-protein interactions, we identified merlin as a NET1-binding protein in a yeast two-hybrid screen. The interaction between NET1 and merlin was confirmed by co-immunoprecipitation. We found that the levels of NET1 protein decreased along with the increase of merlin levels. Furthermore, we demonstrated that merlin facilitates NET1 ubiquitination via the ubiquitin-proteasome pathway. Taken together, this study suggests that NET1 plays an important role in HCC cell migration, invasion, and metastasis, which are key aspects of HCC progression. Furthermore, merlin may serve as a tumor suppressor for HCC by facilitating ubiquitination of NET1.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25113254     DOI: 10.1007/s13277-014-2454-3

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  32 in total

Review 1.  ERM proteins and merlin: integrators at the cell cortex.

Authors:  Anthony Bretscher; Kevin Edwards; Richard G Fehon
Journal:  Nat Rev Mol Cell Biol       Date:  2002-08       Impact factor: 94.444

Review 2.  Radiofrequency ablation versus surgical resection as primary treatment of hepatocellular carcinoma meeting the Milan criteria: a systematic review.

Authors:  Yun Ku Cho; Hyunchul Rhim; Sangik Noh
Journal:  J Gastroenterol Hepatol       Date:  2011-09       Impact factor: 4.029

Review 3.  ERM (ezrin/radixin/moesin) family: from cytoskeleton to signal transduction.

Authors:  S Tsukita; S Yonemura
Journal:  Curr Opin Cell Biol       Date:  1997-02       Impact factor: 8.382

Review 4.  GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors.

Authors:  Kent L Rossman; Channing J Der; John Sondek
Journal:  Nat Rev Mol Cell Biol       Date:  2005-02       Impact factor: 94.444

5.  Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2.

Authors:  M Giovannini; E Robanus-Maandag; M van der Valk; M Niwa-Kawakita; V Abramowski; L Goutebroze; J M Woodruff; A Berns; G Thomas
Journal:  Genes Dev       Date:  2000-07-01       Impact factor: 11.361

Review 6.  Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters.

Authors:  Frank Entschladen; Theodore L Drell; Kerstin Lang; Jan Joseph; Kurt S Zaenker
Journal:  Lancet Oncol       Date:  2004-04       Impact factor: 41.316

Review 7.  Protein 4.1 tumor suppressors: getting a FERM grip on growth regulation.

Authors:  Chun-Xiao Sun; Victoria A Robb; David H Gutmann
Journal:  J Cell Sci       Date:  2002-11-01       Impact factor: 5.285

8.  Merlin, a tumor suppressor, interacts with transactivation-responsive RNA-binding protein and inhibits its oncogenic activity.

Authors:  Joo Yong Lee; Hongtae Kim; Chung Hun Ryu; Jae Young Kim; Byung Hyune Choi; Young Lim; Pil-Woo Huh; Young-Hoon Kim; Kweon-Haeng Lee; Tae-Youn Jun; Hyung Kyun Rha; Joon-Ki Kang; Chang Rak Choi
Journal:  J Biol Chem       Date:  2004-04-27       Impact factor: 5.157

9.  Net1 and Myeov: computationally identified mediators of gastric cancer.

Authors:  J Leyden; D Murray; A Moss; M Arumuguma; E Doyle; G McEntee; C O'Keane; P Doran; P MacMathuna
Journal:  Br J Cancer       Date:  2006-04-24       Impact factor: 7.640

10.  EGFRvIII mediates hepatocellular carcinoma cell invasion by promoting S100 calcium binding protein A11 expression.

Authors:  Xiaoying Luo; Hailong Xie; Xiaolan Long; Min Zhou; Zhibin Xu; Bizhi Shi; Hua Jiang; Zonghai Li
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

View more
  5 in total

1.  Genetic polymorphisms in antioxidant enzyme genes and susceptibility to hepatocellular carcinoma in Chinese population: a case-control study.

Authors:  Song Su; Kai He; Jing Li; Jiali Wu; Mengyu Zhang; Chunhong Feng; Xianming Xia; Bo Li
Journal:  Tumour Biol       Date:  2015-04-19

2.  Genetic polymorphism of HLA-DQ confers susceptibility to hepatitis B virus-related hepatocellular carcinoma: a case-control study in Han population in China.

Authors:  Xia Gao; Wenxuan Liu; Xiaolin Zhang; Longmei Tang; Liqin Wang; Lina Yan; Haitao Yang; Tao Li; Lei Yang; Ning Ma; Dianwu Liu
Journal:  Tumour Biol       Date:  2016-05-21

3.  A structural study of the complex between neuroepithelial cell transforming gene 1 (Net1) and RhoA reveals a potential anticancer drug hot spot.

Authors:  Alain-Pierre Petit; Christel Garcia-Petit; Juan A Bueren-Calabuig; Laurent M Vuillard; Gilles Ferry; Jean A Boutin
Journal:  J Biol Chem       Date:  2018-04-25       Impact factor: 5.157

Review 4.  Association between HLA-DQ Gene Polymorphisms and HBV-Related Hepatocellular Carcinoma.

Authors:  Jingzhu Lv; Tao Xu; Zhongqing Qian; Hongtao Wang
Journal:  Gastroenterol Res Pract       Date:  2017-07-06       Impact factor: 2.260

Review 5.  miRNAs: A Promising Target in the Chemoresistance of Bladder Cancer.

Authors:  Zhonglin Cai; Fa Zhang; Weijie Chen; Jianzhong Zhang; Hongjun Li
Journal:  Onco Targets Ther       Date:  2019-12-31       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.